141 related articles for article (PubMed ID: 17906702)
21. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
22. Treatment of relapsed/refractory multiple myeloma.
Kastritis E; Palumbo A; Dimopoulos MA
Semin Hematol; 2009 Apr; 46(2):143-57. PubMed ID: 19389498
[TBL] [Abstract][Full Text] [Related]
23. New drugs in multiple myeloma.
Berenson JR; Yellin O
Curr Opin Support Palliat Care; 2008 Sep; 2(3):204-10. PubMed ID: 18685422
[TBL] [Abstract][Full Text] [Related]
24. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
Nucci M; Anaissie E
Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
[TBL] [Abstract][Full Text] [Related]
25. An update: health economics of managing multiple myeloma.
Moeremans K; Annemans L
Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867
[TBL] [Abstract][Full Text] [Related]
26. Lenalidomide in multiple myeloma.
Thomas SK; Richards TA; Weber DM
Best Pract Res Clin Haematol; 2007 Dec; 20(4):717-35. PubMed ID: 18070715
[TBL] [Abstract][Full Text] [Related]
27. Role of stem cell transplantation.
Harousseau JL
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
[TBL] [Abstract][Full Text] [Related]
28. Relationship between depth of response and outcome in multiple myeloma.
Dingli D; Pacheco JM; Nowakowski GS; Kumar SK; Dispenzieri A; Hayman SR; Lacy MQ; Gastineau DA; Gertz MA
J Clin Oncol; 2007 Nov; 25(31):4933-7. PubMed ID: 17971591
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma.
Littlewood TJ; Collins GP
Bone Marrow Transplant; 2007 Dec; 40(12):1147-55. PubMed ID: 17846601
[TBL] [Abstract][Full Text] [Related]
30. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
[TBL] [Abstract][Full Text] [Related]
31. Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Spencer A; Prince HM; Roberts AW; Prosser IW; Bradstock KF; Coyle L; Gill DS; Horvath N; Reynolds J; Kennedy N
J Clin Oncol; 2009 Apr; 27(11):1788-93. PubMed ID: 19273705
[TBL] [Abstract][Full Text] [Related]
32. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
33. Myeloma bone disease: pathogenesis and treatment.
Roodman GD;
Oncology (Williston Park); 2005 Jul; 19(8):983-4, 986. PubMed ID: 16131042
[TBL] [Abstract][Full Text] [Related]
34. Expanding role of bortezomib in multiple myeloma: nursing implications.
Colson K; Doss DS; Swift R; Tariman J
Cancer Nurs; 2008; 31(3):239-49. PubMed ID: 18453881
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
36. Role of thalidomide in previously untreated patients with multiple myeloma.
Musto P; D'Auria F; Pietrantuono G; Bringhen S; Morabito F; Di Raimondo F; Pozzi S; Sacchi S; Boccadoro M; Palumbo A; ;
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1569-80. PubMed ID: 18925849
[TBL] [Abstract][Full Text] [Related]
37. Future challenges.
Sirohi B; Powles R
Bone Marrow Transplant; 2007 Dec; 40(12):1157-64. PubMed ID: 17906703
[TBL] [Abstract][Full Text] [Related]
38. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
[TBL] [Abstract][Full Text] [Related]
39. Multiple myeloma in a 50-year-old with an HLA-identical sibling.
Koreth J
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1247-8. PubMed ID: 17889363
[No Abstract] [Full Text] [Related]
40. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
